OXN Oxonica

RNS Number:6102R
Oxonica plc
04 April 2008


4 April 2008

                                  Oxonica plc

          Receipt of US$2.15m of purchase orders for Security Business


Oxonica plc, a leading European nanomaterials group, announces the receipt of
purchase orders totalling US$2.15 million for a number of development products
to be delivered over the seven months through October 2008 as part of a
continuing project with one of the existing customers of Oxonica's security
business.

On completion of the deliveries against these orders, revenue to this customer
will have amounted to US$5.30 million since November 2005.

This new follow-on order is a result of the successful completion of the orders
announced in June, 2007 and the significant technical progress made over the
last six months. The new orders will facilitate process developments to allow
product manufacture on a commercial scale.

Oxonica Security develops covert brand and product security solutions based on
proprietary, patented nanomaterials. The addressable market for this anti-
counterfeiting technology is estimated at US$440 million and comprises
applications in high-value documents, tax stamps, pharmaceuticals, fuel, and
luxury goods.


For further information, please contact:


Oxonica plc                                   01865 856 700

Kevin Matthews, Chief Executive

Richard Clarke, Finance Director



The Broadcast PR Business                     020 7812 6624 and 07734 154310

Matthew Locke



Panmure Gordon                                020 7459 3600

Hugh Morgan

Andrew Potts



Notes to Editors


About Oxonica plc - www.oxonica.com


Oxonica (AIM: OXN.L) is one of the leading international nanomaterials groups
with products already launched into international markets and is listed in
London on the AIM market. It was spun-out from Oxford University in 1999.
Oxonica's mission is to focus on the development of innovative commercial
solutions for international markets using its expertise in the design and
application of nanomaterials. It owns a portfolio of demand driven products that
offer substantial benefits to the target markets of energy, materials, security
and diagnostics.


The Group currently has four operating businesses: Oxonica Energy, Oxonica
Materials, Oxonica Security and Oxonica Diagnostics.  Oxonica has already
launched products into international markets.  Lead products include:

*  EnviroxTM fuel borne catalyst - a catalyst improving fuel economy and 
   reducing emissions

*  OptisolTM UV absorber - a revolutionary photostable UV protection system 
   designed to optimise the performance of quality sunscreens and 
   anti-premature aging products


Oxonica is also engaged in developing a transformational detection technology
that will enable a new generation of rapid, sensitive tests for the in vitro
diagnostic point-of-care testing market. In addition, Oxonica is developing
other UV absorber technologies into polymer systems and coatings, based on
similar technologies to that used in OptisolTM.



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

CNTFKQKQABKKCQK

Oxonica (LSE:OXN)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Oxonica (LSE:OXN)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024